Skip to main content

Drug Interactions between bictegravir / emtricitabine / tenofovir alafenamide and Nexium

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between bictegravir / emtricitabine / tenofovir alafenamide and Nexium. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

bictegravir / emtricitabine / tenofovir alafenamide

A total of 426 drugs are known to interact with bictegravir / emtricitabine / tenofovir alafenamide.

  • Bictegravir / emtricitabine / tenofovir alafenamide is in the drug class antiviral combinations.
  • Bictegravir / emtricitabine / tenofovir alafenamide is used to treat HIV Infection.


A total of 200 drugs are known to interact with Nexium.

Drug and food interactions


esomeprazole food

Applies to: Nexium (esomeprazole)

Food may interfere with the absorption of esomeprazole. Esomeprazole should be taken at least one hour before meals and at the same time every day. When esomeprazole is given to patients receiving continuous enteral nutrition (tube feedings), the tube feeding should be interrupted for at least 1 hour before and 1 hour after the dose of esomeprazole. This will make it easier for your body to absorb the medication. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data


tenofovir food

Applies to: bictegravir / emtricitabine / tenofovir alafenamide

Information for this minor interaction is available on the professional version.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Report options

QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.